CASP8 and cancer: Moreover, pharmacologic blockade of TβR signaling abolished the anti-cancer effects of the SBE4-TRAIL group as evidenced by reduced cleaved caspase-8 and cleaved caspase-3 compared to the group without the inhibitor treatment.